Skip to main content

Detail

Michael Gnant
Professor Michael Gnant, FACSDirector and Chairman

Department of Surgery
Position: Professor

ORCID: 0000-0003-1002-2118
T +43 1 40400 56470
michael.gnant@meduniwien.ac.at

Research group(s)

  • ABCSG
  • Breast Cancer
  • Breast Center
  • Experimental Oncology
  • Minimal Invasive Surgery
  • Oncology
  • Pancreatic Cancer
  • Patient Safety
  • Perioperative Medicine
  • Targeted Therapy

Selected publications

  1. Harbeck, N. & Gnant, M., 2017. Breast cancer. The Lancet, 389(10074), pp.1134-1150. Available at: http://dx.doi.org/10.1016/S0140-6736(16)31891-8.
  2. Gnant, M. et al., 2009. Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer. New England Journal of Medicine, 360(7), pp.679-691. Available at: http://dx.doi.org/10.1056/NEJMoa0806285.
  3. Gnant, M. et al., 2015. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet, 386(9992), pp.433-443. Available at: http://dx.doi.org/10.1016/S0140-6736(15)60995-3.
  4. Coates, A.S. et al., 2015. Tailoring therapies�improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Annals of Oncology, 26(8), pp.1533-1546. Available at: http://dx.doi.org/10.1093/annonc/mdv221.
  5. Gnant, M., Steger, G.G. & Bartsch, R., 2016. Pathological complete remission and long-term outcome�what do we know in 2016? The Lancet Oncology, 17(6), pp.693-694. Available at: http://dx.doi.org/10.1016/S1470-2045(16)30038-9.